Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE AND FINANCING FEES (Details)

v3.21.2
INTEREST EXPENSE AND FINANCING FEES (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Interest Expense and Financing Fee [Line Items]        
Total interest and fees $ 828   $ 1,682  
Dividend payable 365   628  
Installment payments - licenses 170 $ 187 616 $ 492
Total interest and fees 1,373 187 $ 2,936 492
Convertible preferred shares, Conversion premium, Discount rate     15.00%  
Convertible preferred share settlement amount 14,700   $ 14,700  
Anti-Itch product        
Interest Expense and Financing Fee [Line Items]        
Anti-itch product Note 10   10  
Interest        
Interest Expense and Financing Fee [Line Items]        
Convertible preferred shares, Interest 450   1,034  
Dividend payable 365   628  
Installment payments - licenses 170 187 616 492
Total interest 995 $ 187 2,288 $ 492
Interest | Anti-Itch product        
Interest Expense and Financing Fee [Line Items]        
Anti-itch product Note 10   10  
Fees        
Interest Expense and Financing Fee [Line Items]        
Convertible preferred shares, Fees 378   648  
Financing fees $ 378   $ 648